Last updated on June 2019

Safety Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers

Brief description of study

This is a randomized and double-blinded within study group, placebo-controlled trial to evaluate the safety, tolerability and immunological profile of INO-4500 administered by intradermal (ID) injection followed by electroporation using the CELLECTRA 2000 device in healthy adult volunteers.

Clinical Study Identifier: NCT03805984

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.